Immucell ICCC
NASDAQ ICCC
$11.42 +0.67 (+6.23%)
At close: Nov 16, 2026 · 4:00 PM EST

Immucell (ICCC) Gross Margin (2009 - 2026)

Updated

Immucell's Gross Margin came in at 44.22% for Q3 2026, up 1.30 percentage points from 42.92% a year earlier and up 10.30 percentage points from the prior quarter.

Analysis

Immucell (ICCC) Gross Margin (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Immucell reported Gross Margin of 40.83%, down 0.10 percentage points year-over-year; for FY2025, it came in at 41.40%, up 11.43 percentage points from FY2024.

  • Gross Margin carries a five-year change of -3.33 percentage points (FY2020 to FY2025).
  • Going back by year, Gross Margin was 29.97% in FY2024 (+7.83 pp), 22.15% in FY2023 (-19.05 pp), 41.19% in FY2022 (-3.79 pp) and 44.98% in FY2021 (+0.25 pp).
  • The five-year range for quarterly Gross Margin is 8.73% (Q1 2023) to 51.72% (Q1 2022).
  • Year-over-year, Gross Margin increased in six of the last seven quarters, with an average year-over-year change of +6.33 percentage points.
  • The fastest year-over-year change in Gross Margin over five years came in Q1 2024 (a gain of 22.90 percentage points), and the weakest in Q1 2023 (a drop of 43.00 percentage points).
  • Business Quant data shows ICCC's Gross Margin at 33.92% (Q2 2026), 44.97% (Q1 2026) and 38.16% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 68.12%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 75.38%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 72.95%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 88.03%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 73.10%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 81.07%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 75.71%
10 Immucell 102.43 Mn 75.03 Mn 3.56 Mn 44.22%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 44.22%
Jun 30, 2026 33.92%
Mar 31, 2026 44.97%
Dec 31, 2025 38.16%
Sep 30, 2025 42.92%
Jun 30, 2025 43.72%
Mar 31, 2025 41.58%
Dec 31, 2024 36.53%
Sep 30, 2024 26.34%
Jun 30, 2024 22.48%
Mar 31, 2024 31.63%
Sep 30, 2023 23.48%
Jun 30, 2023 29.55%
Mar 31, 2023 8.73%
Dec 31, 2022 25.37%
Sep 30, 2022 38.49%
Jun 30, 2022 44.22%
Mar 31, 2022 51.72%
Dec 31, 2021 47.04%
Sep 30, 2021 46.96%
API Access

Immucell Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY